BR9610214A - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
BR9610214A
BR9610214A BR9610214A BR9610214A BR9610214A BR 9610214 A BR9610214 A BR 9610214A BR 9610214 A BR9610214 A BR 9610214A BR 9610214 A BR9610214 A BR 9610214A BR 9610214 A BR9610214 A BR 9610214A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
BR9610214A
Other languages
Portuguese (pt)
Inventor
Richard E Moore
Vinod Francis Patel
James Edward Ray
John Eldon Toth
Original Assignee
Lilly Co Eli
Univ Hawaii
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Univ Hawaii, Univ Wayne State filed Critical Lilly Co Eli
Publication of BR9610214A publication Critical patent/BR9610214A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9610214A 1995-08-30 1996-08-30 Pharmaceutical compounds BR9610214A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US293595P 1995-08-30 1995-08-30
PCT/US1996/013855 WO1997007798A1 (en) 1995-08-30 1996-08-30 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
BR9610214A true BR9610214A (en) 1999-06-15

Family

ID=21703268

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610214A BR9610214A (en) 1995-08-30 1996-08-30 Pharmaceutical compounds

Country Status (6)

Country Link
EP (2) EP0850316A4 (en)
JP (2) JP2000501067A (en)
AU (2) AU6904896A (en)
BR (1) BR9610214A (en)
CA (2) CA2230540A1 (en)
WO (2) WO1997007798A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000501067A (en) * 1995-08-30 2000-02-02 イーライ・リリー・アンド・カンパニー Pharmaceutical compounds
EP0869786B1 (en) * 1995-12-22 2003-03-05 Eli Lilly And Company Pharmaceutical compounds
AU722492B2 (en) * 1996-08-30 2000-08-03 University Of Hawaii Pharmaceutical compounds
JP2001500484A (en) * 1996-08-30 2001-01-16 イーライ・リリー・アンド・カンパニー Method for producing pharmaceutical compounds
US6680311B1 (en) 1996-08-30 2004-01-20 Eli Lilly And Company Cryptophycin compounds
AU4330097A (en) * 1996-08-30 1998-03-19 Eli Lilly And Company Pharmaceutical compounds
WO1998009601A2 (en) * 1996-09-06 1998-03-12 Eli Lilly And Company Process to prepare pharmaceutical compounds
EP0929556A4 (en) * 1996-09-06 2001-04-18 Lilly Co Eli Process and novel intermediates
JP2001513775A (en) * 1997-02-26 2001-09-04 イーライ・リリー・アンド・カンパニー Tripeptide and tetrapeptide pharmaceutical compounds
EA002547B1 (en) * 1997-02-26 2002-06-27 Эли Лилли Энд Компани Selective epoxidation process for preparing pharmaceutical compounds
EP0870506A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Compositions comprising a cryptophycin compound in combination with a synchronizing or activating agent for treating cancer
EP0870501A1 (en) * 1997-04-11 1998-10-14 Eli Lilly And Company Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections
US6180679B1 (en) * 1998-04-07 2001-01-30 Eli Lilly And Company Method for treating fungal infections
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
US6376230B1 (en) 1998-10-16 2002-04-23 Eli Lilly And Company Stereoselective process for producing intermediates of cryptophycins
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
WO2003077906A1 (en) * 2002-03-18 2003-09-25 Nihon University Cyclic etheramine derivatives as medicaments for malignant tumors
US7229814B2 (en) 2004-05-05 2007-06-12 Regents Of The University Of Minnesota Nucleic acids and polypeptides involved in the production of cryptophycin
JPWO2007000994A1 (en) * 2005-06-28 2009-01-22 中外製薬株式会社 Method for producing compound having anti-HCV action
CN103724290B (en) * 2013-11-15 2015-04-29 浙江大学 Cyclopeptide compound clavatustide A as well as producing strain, preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868208A (en) * 1988-07-15 1989-09-19 Merck & Co., Inc. Antifungal agent and method
US4946835A (en) * 1988-07-15 1990-08-07 Merck & Co., Inc. Antifungal fermentation product and method
US4845086A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US4845085A (en) * 1988-08-09 1989-07-04 Merck & Co., Inc. Antifungal agent
US5952298A (en) * 1993-12-21 1999-09-14 The University Of Hawaii Cryptophycins
EP0830136B1 (en) * 1995-03-07 2004-10-20 University Of Hawaii New cryptophycins from synthesis
JP2000501067A (en) * 1995-08-30 2000-02-02 イーライ・リリー・アンド・カンパニー Pharmaceutical compounds

Also Published As

Publication number Publication date
EP0850057A4 (en) 2001-04-11
AU709828B2 (en) 1999-09-09
EP0850057A1 (en) 1998-07-01
WO1997007798A1 (en) 1997-03-06
AU7109096A (en) 1997-03-19
AU6904896A (en) 1997-03-19
WO1997008334A1 (en) 1997-03-06
EP0850316A4 (en) 2000-08-23
CA2230540A1 (en) 1997-03-06
JP2000507805A (en) 2000-06-27
JP2000501067A (en) 2000-02-02
EP0850316A1 (en) 1998-07-01
CA2246117A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
NO20004345L (en) Pharmaceutical composition
ID16345A (en) HETEROSICLIC COMPOUNDS
PT858325E (en) STABILIZED PHARMACEUTICAL PHARMACEUTICAL FORMULA
FI973518A (en) Pharmaceutical composition for piperidinoalkanol compounds
IS4706A (en) pharmaceutical compositions
BR9610153A (en) Pharmaceutical formulations
FI972970A (en) New compounds
DK0783302T3 (en) drugs
ATE258166T1 (en) SUBSTITUTED BENZYLAMINPIPERIDINE COMPOUNDS
BR9600534A (en) New compounds
BR9610396A (en) Pharmaceutical formulation
BR9610214A (en) Pharmaceutical compounds
EE9800172A (en) Compounds
BR9600809A (en) Medication
BR9607626A (en) New pharmaceutical naphthyl compounds
LV11727A (en) Pharmaceutical composition
NO974170D0 (en) Polyazacykloalkan compounds
FI973280A0 (en) Pharmaceutical composition
PT850048E (en) PHARMACEUTICAL GRANULES
FI973230A (en) New pharmaceutical formulation
NO965448D0 (en) Pharmaceutical compounds
DE59610423D1 (en) PARTICULAR MEDICINE
BR9605777A (en) Pharmaceutical composition
NO964309D0 (en) Pharmaceutical composition
NO962816D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
FA14 Dismissal: dismissal - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]